Portions of this manuscript have been presented in poster format at the Eating Disorders Research Society Meeting, Brooklyn New York, 2009.
A prevalence study and Description of alli® use by patients with eating disorders†
Version of Record online: 7 MAY 2010
Copyright © 2010 Wiley Periodicals, Inc.
International Journal of Eating Disorders
Volume 43, Issue 5, pages 472–479, July 2010
How to Cite
Steffen, K. J., Mitchell, J. E., le Grange, D., Crow, S. J., Attia, E., Bulik, C. M., Dellava, J. E., Bermudez, O., Erickson, A. L., Crosby, R. D. and Bansal-Dev, V. P. (2010), A prevalence study and Description of alli® use by patients with eating disorders. Int. J. Eat. Disord., 43: 472–479. doi: 10.1002/eat.20829
- Issue online: 1 JUN 2010
- Version of Record online: 7 MAY 2010
- Manuscript Accepted: 4 MAR 2010
- 1National Center for Health Statistics. Chartbook on Trends in the Health of Americans. Hyattsville, MD: Public Health Service, 2006.
- 2Weighing alli's impact. Eating disorder patients might be tempted to abuse the first FDA-approved nonprescription diet pill. Behav Healthc 2007; 27: 32–34., , .
- 4Alli Homepage for HealthCare Professionals, GlaxoSmithKline. http://www.allihcp.com. Accessed May 2009.
- 5Micromedex® Healthcare Series (n.d.). Retrieved January, 2009, from http://www.thomsonhc.com. Greenwood Village, CO: Thomson Healthcare.